These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24732189)

  • 1. Gastric barrier function and toxic damage.
    Niv Y; Banić M
    Dig Dis; 2014; 32(3):235-42. PubMed ID: 24732189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric mucosal defense and cytoprotection: bench to bedside.
    Laine L; Takeuchi K; Tarnawski A
    Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heat shock proteins in gastric inflammation and ulcer healing.
    Choi SR; Lee SA; Kim YJ; Ok CY; Lee HJ; Hahm KB
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():5-17. PubMed ID: 20388941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrients affecting gastric barrier.
    Gasbarrini A; D'Aversa F; Di Rienzo T; Franceschi F
    Dig Dis; 2014; 32(3):243-8. PubMed ID: 24732190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
    Laine L
    Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological, immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori-derived gastrotoxins.
    Konturek PC
    J Physiol Pharmacol; 1997 Mar; 48(1):3-42. PubMed ID: 9098824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Slomiany BL; Piotrowski J; Slomiany A
    J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiopathogenetic principles and peptic ulcer disease classification.
    Tytgat GN
    Dig Dis; 2011; 29(5):454-8. PubMed ID: 22095009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAID-induced gastric injury: its pathogenesis and management.
    Earnest DL
    Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 2):6-10. PubMed ID: 2181675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
    Konturek JW; Fischer H; Konturek PC; Huber V; Boknik P; Luess H; Neumann J; Brzozowski T; Schmitz W; Hahn EG; Domschke W; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):153-64. PubMed ID: 11321509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
    Wallace JL
    Physiol Rev; 2008 Oct; 88(4):1547-65. PubMed ID: 18923189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin C-releasing acetylsalicylic acid on gastric mucosal damage before and after Helicobacter pylori eradication therapy.
    Konturek PC; Kania J; Gessner U; Konturek SJ; Hahn EG; Konturek JW
    Eur J Pharmacol; 2004 Dec; 506(2):169-77. PubMed ID: 15588738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some new aspects of gastric mucosal protection and damage.
    Bennett A
    Acta Physiol Hung; 1989; 73(2-3):179-83. PubMed ID: 2688358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.